A detailed history of Lloyd Advisory Services, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Lloyd Advisory Services, Llc. holds 8,550 shares of ABBV stock, worth $1.47 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
8,550
Previous 1,792 377.12%
Holding current value
$1.47 Million
Previous $277,000 461.73%
% of portfolio
0.5%
Previous 0.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$159.82 - $182.1 $1.08 Million - $1.23 Million
6,758 Added 377.12%
8,550 $1.56 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $915,452 - $1.03 Million
-6,653 Reduced 78.78%
1,792 $277,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $1.13 Million - $1.31 Million
8,445 New
8,445 $1.26 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $320,516 - $407,481
-2,329 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $42,497 - $52,727
-322 Reduced 12.15%
2,329 $378,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $1,504 - $1,903
14 Added 0.53%
2,651 $359,000
Q3 2021

Oct 21, 2021

SELL
$106.4 - $120.78 $5,213 - $5,918
-49 Reduced 1.82%
2,637 $284,000
Q2 2021

Aug 09, 2021

SELL
$105.21 - $117.21 $1,157 - $1,289
-11 Reduced 0.41%
2,686 $303,000
Q1 2021

May 04, 2021

SELL
$102.3 - $112.62 $2,557 - $2,815
-25 Reduced 0.92%
2,697 $292,000
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $15,132 - $20,429
-188 Reduced 6.46%
2,722 $292,000
Q3 2020

Oct 28, 2020

SELL
$85.91 - $100.83 $73,195 - $85,907
-852 Reduced 22.65%
2,910 $255,000
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $33,603 - $44,966
-458 Reduced 10.85%
3,762 $369,000
Q1 2020

Jun 03, 2020

SELL
$64.5 - $97.79 $32,701 - $49,579
-507 Reduced 10.73%
4,220 $322,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $340,958 - $426,611
4,727 New
4,727 $419,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lloyd Advisory Services, Llc. Portfolio

Follow Lloyd Advisory Services, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lloyd Advisory Services, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Lloyd Advisory Services, Llc. with notifications on news.